"If you do only one blood sample at each of these time points, just by chance you could see an effect," Anawalt says. "Those supplement studies are a bunch of hooey," says Anawalt. There’s also variation in how individual men feel at a given testosterone level. And about 30 percent of men who have low testosterone according to one measurement will have normal testosterone on the next. And levels need to be measured on more than one occasion because they fluctuate wildly.
Testosterone levels are highest at 8 a.m. Your levels go up and down during the day. Once your results come back, your doctor may order other tests to rule out other reasons for your low T levels. You might confuse low testosterone (low T) with erectile dysfunction.
That is, you throw a little kerosene on the cancer, and it kicks off." "That’s a disease that develops over many years." "You cannot extrapolate from this study to 20-year safety," Anawalt acknowledges. The men were randomly assigned to use a testosterone gel or a placebo gel for an average of nearly two years and were followed for roughly one more year. At the behest of the Food and Drug Administration, pharmaceutical companies that sell testosterone tried to find out.
None of the studies that have tested testosterone replacement therapy lasted more than a few years. Its results provide some optimism for men with hypogonadism who may have stayed away from testosterone replacement therapy because they were afraid of what it might do to their heart. And while the effect isn’t permanent, studies using testosterone as a male contraceptive suggest that it can take 6 months to two years for sperm to return to normal after discontinuing testosterone therapy.
Several limitations of this study are noteworthy, as it is open to criticism given very complex statistical methodology Traisch et al. 2014. To date, the literature has been conflicting, suggesting TRT has either no beneficial effect on reduction of cardiovascular morbidity or mortality, or even a detrimental effect. The potential that TD may be involved in the pathogenesis of CVD would create a notion that TRT would result in improved cardiovascular outcomes, yet no current evidence exists to support this claim. The highlighted studies addressed in this paper can be used to guide the clinician in how to best monitor patients on TRT, especially those with the comorbid conditions detailed below.